GO
Loading...

Eli Lilly and Co

More

  • Early Glance: Pharmaceuticals companies Thursday, 23 Oct 2014 | 11:56 AM ET

    Baxter International Inc. rose$. 59 or. 9 percent, to $68.96. Bristol-Myers Squibb Co. rose$. 36 or. 7 percent, to $52.20. Hospira rose$. 74 or 1.5 percent, to $50.82.

  • Oct 23- Eli Lilly and Co said its quarterly earnings plunged 58 percent, hurt by special charges and generic competition for its Cymbalta depression drug, but it affirmed its earlier full-year profit forecast. The U.S. drugmaker on Thursday said it had earned $501 million, or 47 cents per share, in the third quarter. Sales fell 16 percent to $4.88 billion, but topped...

  • Lilly profit plunges as cheaper generics take toll Thursday, 23 Oct 2014 | 6:50 AM ET

    Oct 23- Eli Lilly and Co said its quarterly earnings plunged 58 percent, hurt by special charges and generic competition for its Cymbalta depression drug, but it affirmed its earlier full-year profit forecast. The U.S. drugmaker on Thursday said it had earned $501 million, or 47 cents per share, in the third quarter. Sales fell 16 percent to $4.88 billion, but topped...

  • Lilly meets 3Q profit forecasts Thursday, 23 Oct 2014 | 6:39 AM ET

    INDIANAPOLIS— Eli Lilly and Co. on Thursday reported net income of $500.6 million in its third quarter. The average estimate of analysts surveyed by Zacks Investment Research was also for earnings of 66 cents per share. Analysts expected $4.84 billion, according to Zacks.

  • Final Glance: Pharmaceuticals companies Wednesday, 22 Oct 2014 | 6:09 PM ET

    Baxter International Inc. fell$. 28 or. 4 percent, to $68.37. Bristol-Myers Squibb Co. fell$. 11 or. 2 percent, to $51.84. Hospira fell$. 80 or 1.6 percent, to $50.08.

  • Eli Lilly adds $375M to Zymeworks partnership Wednesday, 22 Oct 2014 | 5:12 PM ET

    NEW YORK— Eli Lilly and Zymeworks said Wednesday they are expanding a cancer drug development partnership. Without explaining the initial terms of the partnership, the companies said Zymeworks could get an additional $375 million in milestones and other payments. Shares in Indianapolis- based Eli Lilly and Co. were unchanged at $64.68 on Wednesday.

  • Midday Glance: Pharmaceuticals companies Wednesday, 22 Oct 2014 | 1:18 PM ET

    Baxter International Inc. fell$. 24 or. 3 percent, to $68.41. Bristol-Myers Squibb Co. fell$. 01 or percent, to $51.94. Hospira rose$. 09 or. 2 percent, to $50.97.

  • Early Glance: Pharmaceuticals companies Wednesday, 22 Oct 2014 | 10:36 AM ET

    Baxter International Inc. rose$. 17 or. 2 percent, to $68.82. Bristol-Myers Squibb Co. rose$. 02 or percent, to $51.97. Hospira rose$. 06 or. 1 percent, to $50.94.

  • Final Glance: Pharmaceuticals companies Tuesday, 21 Oct 2014 | 6:01 PM ET

    Baxter International Inc. rose$. 71 or 1.0 percent, to $68.65. Bristol-Myers Squibb Co. rose $1.39 or 2.7 percent, to $51.95. Hospira rose $1.01 or 2.0 percent, to $50.88.

  • Midday Glance: Pharmaceuticals companies Tuesday, 21 Oct 2014 | 1:43 PM ET

    Baxter International Inc. rose$. 28 or. 4 percent, to $68.22. Bristol-Myers Squibb Co. rose$. 81 or 1.6 percent, to $51.37. Hospira rose$. 24 or. 5 percent, to $50.11.

  • Early Glance: Pharmaceuticals companies Tuesday, 21 Oct 2014 | 11:56 AM ET

    Baxter International Inc. rose$. 07 or. 1 percent, to $68.01. Bristol-Myers Squibb Co. rose$. 42 or. 8 percent, to $50.98. Hospira rose$. 22 or. 4 percent, to $50.09.

  • Final Glance: Pharmaceuticals companies Monday, 20 Oct 2014 | 6:05 PM ET

    Baxter International Inc. rose$. 70 or 1.0 percent, to $67.94. Bristol-Myers Squibb Co. rose$. 14 or. 3 percent, to $50.56. Hospira fell$. 20 or. 4 percent, to $49.87.

  • Midday Glance: Pharmaceuticals companies Monday, 20 Oct 2014 | 1:23 PM ET

    Baxter International Inc. rose$. 18 or. 3 percent, to $67.42. Bristol-Myers Squibb Co. fell$. 17 or. 3 percent, to $50.25. Hospira fell$. 18 or. 4 percent, to $49.89.

  • Early Glance: Pharmaceuticals companies Monday, 20 Oct 2014 | 10:40 AM ET

    Baxter International Inc. rose$. 02 or percent, to $67.26. Bristol-Myers Squibb Co. rose$. 03 or. 1 percent, to $50.45. Hospira rose$. 25 or. 5 percent, to $50.32.

  • Final Glance: Pharmaceuticals companies Friday, 17 Oct 2014 | 6:03 PM ET

    Baxter International Inc. fell$. 94 or 1.4 percent, to $67.24. Bristol-Myers Squibb Co. rose $1.20 or 2.4 percent, to $50.42. Hospira rose$. 40 or. 8 percent, to $50.07.

  • Midday Glance: Pharmaceuticals companies Friday, 17 Oct 2014 | 1:21 PM ET

    Baxter International Inc. fell$. 35 or. 5 percent, to $67.83. Bristol-Myers Squibb Co. rose $1.49 or 3.0 percent, to $50.71. Hospira rose$. 36 or. 7 percent, to $50.03.

  • Early Glance: Pharmaceuticals companies Friday, 17 Oct 2014 | 10:39 AM ET

    Baxter International Inc. fell$. 47 or. 7 percent, to $67.71. Bristol-Myers Squibb Co. rose$. 49 or 1.0 percent, to $49.71. Hospira fell$. 19 or. 4 percent, to $49.48.

  • Final Glance: Pharmaceuticals companies Thursday, 16 Oct 2014 | 6:02 PM ET

    Baxter International Inc. fell$. 16 or. 2 percent, to $68.18. Bristol-Myers Squibb Co. rose$. 26 or. 5 percent, to $49.22. Hospira rose $1.55 or 3.2 percent, to $49.67.

  • Midday Glance: Pharmaceuticals companies Thursday, 16 Oct 2014 | 1:21 PM ET

    Baxter International Inc. rose$. 65 or 1.0 percent, to $68.99. Bristol-Myers Squibb Co. rose$. 30 or. 6 percent, to $49.26. Hospira rose$. 61 or 1.3 percent, to $48.73.

  • Early Glance: Pharmaceuticals companies Thursday, 16 Oct 2014 | 11:35 AM ET

    Baxter International Inc. fell $1.01 or 1.5 percent, to $67.33. Bristol-Myers Squibb Co. rose$. 25 or. 5 percent, to $49.21. Hospira rose$. 32 or. 7 percent, to $48.44.